Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein shisa-9 (SHISA9, also known as CKAMP44) is a transmembrane auxiliary protein that regulates short-term neuronal synaptic plasticity, primarily in the dentate gyrus of the hippocampus[2][4][6]. It associates with AMPA-type ionotropic glutamate receptors in synaptic spines, promoting AMPA receptor desensitization at excitatory synapses and modulating receptor trafficking and postsynaptic neurotransmitter receptor activity[1][6]. Protein shisa-9 interacts with several synaptic scaffold proteins and is dynamically regulated by Protein kinase C (PKC) signaling, contributing to synaptic plasticity mechanisms in the central nervous system[1]. Disease associations have been observed for epilepsy and autism spectrum disorder[2]. There is currently no evidence that SHISA9 is itself a direct therapeutic target for any approved or investigational drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein shisa-9 (SHISA9).